HIPAA Act of 1996 :: Health, Health Information

The Health Insurance Portability and Ac seeability knead (HIPAA) of 1996 made it illegal to gain access to personal medical data for any reasons other than health superintend delivery, operations, and reimbursements (Shi & Singh, 2008, p. 166). HIPAA legislation mandated strict controls on the transfer of personally identifiable health data between two entities, provisions for disclosure of protected information, and criminal penalties for violation (Clayton 2001). HIPAA also has cover requirements that govern disclosure of uncomplaining protected health information (PHI) determined in the medical record by physicians, nurses, and other health care providers (Buck, 2011). Always remember conversations about a patients health care or treatment is a violation of HIPAA. All PHI is include in the privacy requirements for example the patients past, present or future physical or mental health or agree the provision of health care to the individual, or the past, present, or future recompense for the provision of health care to the individual, and that identifies the individual or for which there is a reasonable basis to believe it can be used to let on the individual (Buck, 2011). Other identifiable health information would be the patients name, address, birth date and Social Security Number (Keomouangchanh, 2011). (Word count 197)There has been some ethical issues surrounding the development and use of technology, that would comprise of some advancements, such as when in vitro salad dressing is applied in medical practice and leads to the production of spare embryos, the moral question is what to do with these embryos (Shi & Singh, 2008, p. 182). As for ethical dilemmas that comes into play with gene mapping of humans, genetic cloning, hold cell research, and others areas of growing interest to scientist (Shi & Singh, 2008, p. 182). Life support technology raises severe ethical issues, especially in medical decisions regarding continuation or result of mechanical support, particularly when a patient exists in a everlasting vegetative state (Shi & Singh, 2008, p. 182). Health care budgets are limited passim this world, making it hard for advancements yet even harder to develop the advancements with restraints. Which brings us rear end to the social, ethical, and legal constraints, public and private insurers face the problem deciding whether or not to cover novel treatments 188. Similarly what was mentioned before the decisions about cutting reproductive techniques such as intracytoplasmic sperm injection in vitro fertilization (ICSIIVF), new molecular genetics predictive tests for hereditary breast cancer, and the newer drugs such as sildenafil (Viagra) for sexual dysfunction (Giacomini, 2005).